Search results for: 'biologicals antibodi reagents us'

11 Apr 2024  |  North America  |  Market Research

Global Blood Group Typing Industry, Forecast to 2028

Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities

Infographics

×

This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anem...

10 Mar 2015  |  North America  |  Market Research

The US Blood Transfusion Diagnostics Market

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

Infographics

×

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

AI has moved from a standalone technology to a core building block that drives global business growth. AI adoption is increasingly critical for international businesses to stay competitive. Improved efficiency and productivity and the need to gain a competitive edge drive the rising adoption of AI among businesses. Understanding AI use cases and a...

The COVID-19 pandemic led to the rapid scaling up of production activities in the pharmaceutical industry. An increase in the number of FDA approvals in biologics has further accelerated biopharmaceutical production, particularly in North America and Asia. With a boom in biopharmaceuticals anticipated in the next 5 to 7 years, the demand for single...

This Frost & Sullivan research service focuses on US Department of Defense (DoD) satellite growth budget spending and contracts. The study includes research, development, test, and evaluation (RDT&E); procurement; operations and maintenance (O&M); and other services. Satellite spending for the fiscal year 2025 DoD budget request is the foundati...

This report analyzes the world chemical and biological warfare agent detection markets. The report consists of the following sections: total market overview, executive summary, and three segment chapters focusing on chemical, biological and homeland security niche markets. Total market size is presented along with regional market discussions. In...

The world chemical and biological agent detection market report covers all topics related to this industry. The size of the U.S. market, both military and civilian, is discussed in detail. The world market, which, includes European, Asian, and Middle Eastern markets are also covered. While analyzing the market, the total market size as well as mark...